Kohlberg Kravis Roberts & Co »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 13M 0.92
2023-09-30 $14M 15M 0.93

More positions owned by Kohlberg Kravis Roberts & Co

Bridgebio Pharma (BBIO)
Brightview Holdings (BV)
Fs Kkr Capital Corp (FSK)
Applovin Corp Com Cl A (APP)
Propertyguru Group Ord Shs (PGRU)
Kkr Real Estate Finance Trust (KREF)
Endeavor Group Hldgs Cl A Com (EDR)
Ncl Corp Note 1.125% 2/1 (Principal)
Transphorm (TGAN)
Doordash Cl A (DASH)
Jetblue Airways Corp Note 0.500% 4/0 (Principal)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Marriott Vacations Worldwide Note 1/1 (Principal)
Redfin Corp Note 10/1 (Principal)
Realogy Grp Llc/realogy Note 0.250% 6/1 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1